The ZEUS and Lp(a)HORIZON cardiovascular trials have shown that modifying a specific biological marker does not necessarily translate to better patient health outcomes. These studies highlight a critical gap between biomarker alteration and tangible improvements in patient well-being. AI
RANK_REASON The cluster reports on findings from two major clinical trials, which falls under research. [lever_c_demoted from research: ic=1 ai=0.0]
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →